Here we describe the presence of two very similar but unusual variants of AmpC cephalosporinase in each Cronobacter sakazakii and C. malonaticus isolates conferring resistance exclusively to first generation cephalosporins. During a survey on the antibiotic resistance patterns of C. sakazakii and C. malonaticus strains isolated from a milk powder production facility, originally two different phenotypes regarding the susceptibility/resistance for the two beta-lactam antibiotics ampicillin (amp) and cephalothin (ceph) were observed: (i) isolates being susceptible for both antibiotics (amp S /ceph S ), and (ii) strains exhibiting susceptibility to ampicillin but resistance to cephalothin (amp S /ceph R ). The latter phenotype (amp S /ceph R ) was observed in the majority of the environmental strains from the facility. Analysis of whole genome sequences of C. sakazakii revealed a gene putatively coding for an AmpC beta-lactamase. Consequently, the ampC genes from both species and both phenotypes were subjected to a cloning approach. Surprisingly, when expressed in Escherichia coli, all transformants exhibited the amp S /ceph R phenotype regardless of (i) the phenotypic backgrounds or (ii) the AmpC amino acid sequences of the original strains from which the clones were derived. The novel AmpC beta-lactamases were designated CSA-1 and CSA-2 (from C. sakazakii) and CMA-1 and CMA-2 (from C. malonaticus). The observed variations in the minimum inhibitory concentration (MIC) levels for cephalothin (wt compared to transformants) suggest that this feature is a target of a yet unknown regulatory mechanism present in the natural Cronobacter background but absent in the neutral E. coli host.
Introduction
A ccording to the List of Prokaryotic Names with Standing in Nomenclature (www.bacterio.net/allnamesac.html), the genus Cronobacter was proposed in 2008 and currently consists of seven species, which encompass organisms previously identified as Enterobacter sakazakii. 8, 9 Members of this genus are considered opportunistic pathogens, and are associated with outbreaks and sporadic infections, particularly in low birth weight and premature infants. 1, 12, 13 Symptoms include bacteremia, necrotizing enterocoliti,s and meningitis, with fatality rates between 10% and 42%. 6 The prognosis for survivors is generally poor, and neurological delay and poor lifelong outcomes may occur in more than 74% of cases. 19 Antibiotic susceptibility testing, when available, showed that Cronobacter isolates were usually sensitive to ampicillin, the aminoglycosides, chloramphenicol, and third generation cephalosporins. 13 However, in a study by Lai, 10 cases of nosocomial Cronobacter infections were examined, thereby revealing that all of the isolates were uniformly resistant to ampicillin, cephazolin, and extended spectrum penicillins, and were not uniformly susceptible to the third generation cephalosporins.
Antimicrobial susceptibility testing on environmental Cronobacter spp. isolates, as performed in more recent studies, indicated susceptibility to ampicillin (and all cephalosporins), thus leading to speculations that Cronobacter wild type strains may lack a beta-lactamase. 4, 7 Genera such as Enterobacter, Citrobacter, Serratia, Proteus, Providencia, and Morganella usually express a chromosomal, inducible group I AmpC type beta-lactamase that confers strong resistance to penicillins (including ampicillin and inhibitor combinations) and first to third generation cephalosporins.
11
In this study, we analyzed C. sakazakii and C. malonaticus strains originating from a milk powder production facility and respective species type strains for their antimicrobial resistance against the two major beta-lactam antibiotics-ampicillin and cephalothin-in order to answer the question of the presence/ expression of a beta-lactamase in Cronobacter.
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Material and Methods

Strains and antibiotic susceptibility testing
In a study by Müller et al., 14 139 C. sakazakii and C. malonaticus isolates from a milk powder production facility were collected and characterized using several typing methods. These isolates were examined in this study for their resistance against major antibiotics using the disk diffusion assay, 3 as well as by determining the minimum inhibitory concentration (MIC) values by means of the E-Test (Biomerieux) for four selected strains, two from the above mentioned study-C. sakazakii Su 92 and C. malonaticus Su 126-as well as two type strains-C. sakazakii ATCC 29544
T and C. malonaticus type strain LMG 23826 T . Escherichia coli DH5 alpha as well as E. coli DH5 alpha harboring the pCCR9 cloning vector were included in the study. Cronobacter strains and E. coli DH5 alpha were cultivated in LB, transformants and E. coli DH5 alpha harboring pCCR9 18 vector were grown in LB supplemented with tetracycline (50 mg/L) at 37°C overnight. Strains used in the study and respective susceptibility data are given in Table 1 .
Identification of a putative beta-lactamase gene in C. sakazakii ES15 and primer design A database search was performed on the whole genome sequence available for C. sakazakii ES15 (GenBank: CP003312.1) and a coding sequence (CDS) annotated as putative beta-lactamase (ampC, GenBank: AFJ99606. 
Sequencing and sequence analysis
Sequencing of the ampC amplicons and the respective transformant inserts was outsourced (Microsynth). Sequence analysis was performed using the CLC Main Workbench 5 software.
Cloning of ampC CDS ( + promoter element)
For cloning purposes, the above mentioned primers were extended by a HindIII (forward primer) and a BamHI (reverse primer) restriction enzyme recognition sequence. The amplicons were double digested, purified using the Qiagen PCR purification Kit. Vector pCCR9 DNA was obtained using the Qiagen Plasmid Midi Kit double digested with the above mentioned enzymes, (0.7% agarose) gel purified, and DNA was released employing the Qiagen Gel purification Kit. Vector-insert ligation was performed using the T4 ligase (New England Biolabs). Constructs were transformed in E. coli DH5 alpha cells by electroporation.
Accession numbers
The ampC gene sequences of the isolates included in this study were deposited in Genbank under the following numbers: C. sakazakii ATCC 29544 T (encoding AmpC, which was designated CSA-1) = KF623543; C. sakazakii Su 92 (encoding AmpC, which was designated CSA-2) = KF640250; C. malonaticus LMG 23826 T (encoding AmpC, which was designated CMA-1) = KF640251; C. malonaticus Su126 (encoding AmpC, which was designated CMA-2) = KC665723. Based on these data, primers were designed spanning the CDS, including a putative promoter element. The putative ampC genes were successfully amplified in all four target strains, and amplicons were subjected to sequencing.
Deduced protein sequences revealed that the four Cronobacter AmpC showed the highest-although still relatively low-protein homology to AmpC in Serratia marcescens SST-1 (65-66% identity, BAA23131) and Pantoea sp. At-9b (68-69% identity, YP_004115822.1). In Fig. 1 , the nucleic acid alignment of the 5¢ untranslated (promoter) region (1A), the amino acid alignment of the translated CDS (1B), as well as the nucleic acid alignment of the 3¢ untranslated region of the four Cronobacter AmpC sequences, including the Serratia marcescens SST-1 (AB008455.1, BAA23131) and Pantoea sp. At-9b (YP_004115822.1) (1C), is depicted.
The ampC CDS of the four Cronobacter strains originally exhibiting divergent cephalothin resistance patterns were cloned and expressed in E. coli DH5 alpha. Determination of the MICs by means of the E-tests revealed (although with minor variations) identical susceptibility patterns for all transformants, namely susceptibility to ampicillin and resistance to cephalothin, according to CLSI interpreting criteria (Table 1) .
AmpC beta-lactamases are cephalosporinases from the functional group 1 and molecular class C in the BushJacoby-Medeiros classification scheme of beta-lactamases. They are not inhibited by beta-lactamase inhibitors such as clavulanic acid. Additionally, certain beta-lactams such as cefoxitin, clavulanic acid, and carbapenems are strong AmpC beta-lactamase inducers. In order to test a potential induction effect possibly affecting the phenotype for cephalothin, double disk experiments were carried out using either amoxicillin/clavulanic acid or cefoxitin as inducers. For this purpose, the potential inducer disk was placed adjacent to three cephalothin disks, separated by distances of 10, 15, and 25 mm respectively, on Mueller Hinton agar. Figure 2 exemplifies the results of these experiments for the cefoxitin/cephalothin combination. No antagonistic effect was observed, as would have been expected in the case of induction. Results from analogous experiments using amoxicillin/clavulanic acid as an inducer were comparable (data not shown). In conclusion, the results showed that (i) Cronobacter wt and respective E. coli ampC transformants were fully susceptible to cefoxitin, and (ii) no induction effect was observed.
In many organisms, including Enterobacter spp., the expression/induction of the ampC appears to involve several gene products associated with this regulation. These gene products include AmpR, AmpD, and AmpG. Performing a GenBank homology search for these regulatory elements revealed that both C. sakazakii and C. malonaticus harbor homologues for AmpG and AmpD. However, no homologue could be identified for the key AmpC regulator AmpR in either of the two species (data not shown). This finding (i.e., absence of ampR) is further evidence in support of our experimental observation of the Cronobacter beta-lactamase being noninducible. 22 
Discussion
The presence/expression of a beta-lactamase in Cronobacter has been discussed controversially in the literature. Several studies have suggested that Cronobacter is susceptible to beta-lactam antibiotics. 13, 15, 21 However, the presence of beta-lactamases in Cronobacter was confirmed in a study by Pitout et al. 17 who showed that Cronobacter strains sensitive to all cephalosporins, including cefoxitin, produced Bush group 1 beta-lactamases with isoelectric points of 7.4-8.0 at low levels. Enterobacteriaceae species, which naturally express their beta-lactamases at negligible or low levels, are not uncommon, and include several species (e.g., Shigella spp., 16 Proteus mirabilis, 11 and Edwardsiella tarda 20 ). We used a cloning approach in order to answer the question of the presence and the expression of a (AmpC) type beta-lactamase in Cronobacter isolates. This was a somewhat surprising result, as the strains were originally selected due to the observed differences in their resistance to cephalothin in their wild type background. The higher MIC values for ampicillin in the transformants may be explained as ''gene dosage effect,'' that is, copy (and thus the gene copy) number of the (low copy) pCCR9 18 vector versus single chromosomal copy. By this approach, we could show that C. sakazakii and C. malonaticus possess group C betalactamases 2 with a highly specialized phenotype. The sequences of the novel AmpC beta-lactamases were deposited in GenBank and designated as follows: CSA-1 (C. sakazakii ATCC 29544 T ); CSA-2 (C. sakazakii Su 92); CMA-1 (C. malonaticus LMG 23826 T ); and CMA-2 (C. malonaticus Su 126). The divergences in cephalothin MIC values, as observed before and after cloning of the ampC genes of Cronobacter strains exhibiting the amp S /ceph S phenotype, may be explained by the presence of yet unknown influencing factors present in the natural Cronobacter background, but absent in E. coli.
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